analyst snapshot


Growth Story Still Intact for Novavax Inc. (NVAX)

Last week, shares of biotech company Novavax Inc. (NASDAQ: NVAX) are up more than 37% to trade at $51.67 on June 24. A growth factor was the announcement that the Novavax COVID-19 vaccine will be licensed in Europe for adolescents. from 12 to 17 years old. The European Agency for

Read More »
AZN Stock

AstraZeneca Plc. (AZN) Moves In The Right Direction

AstraZeneca Plc. (NASDAQ: AZN) filed an application with the FDA last month to have a combination of two medications approved as a therapy for inoperable liver cancer. Wall Street estimates the treatment may generate $1 billion in revenue per year. AZN intends to treat inoperable advanced liver cancer with a

Read More »
LTHM stock

Livent Corp (LTHM) stock: In Limelight?

This week, lithium producers Albemarle and Livent announced solid profits and upped their sales expectations for 2022, owing to higher lithium prices, which are highly sought by electric car manufacturers. This year, lithium stocks have remained hot as global electric vehicle manufacturers ramp up output. Furthermore, due to Russia’s war

Read More »
ENSV Stock

For A Defensive Strategy: Lucid Group Inc. (LCID)

On Wednesday, April 27, Lucid Group Inc. (NASDAQ: LCID) reported a significant order. The corporation intends to begin implementing the order in 2023. The shares of the company rose in response to the news, reaching $18.89 in trading on April 28. The Lucid Group (LCID) concentrates on the premium electric

Read More »

Just How Strong Are NextEra Energy Inc. (NEE) Financial Foundations?

NextEra Energy Inc. (NYSE: NEE), a utility focusing on green energy delivery, recently announced a revenue increase in the first quarter. Consumers’ growing “environmental consciousness” and rising traditional fuel prices are becoming additional growth factors. NextEra Energy’s revenue increased by more than 10% year over year to $1.5 billion in

Read More »



Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam